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patients was 14%. There was no evidence of stent migration. 
Conclusion: We observed strut fractures in 13.6% of the nitinol SFA stents at 18 mos. 
mean follow-up. Restenosis defined by arterial duplex doppler occurred in 14% of all 
StentS and in 7% of fractured stents. Fluoroscopic and arterial duplex-doppler follow-up 
of the entire 76 patient cohort (105 stems) is ongoing. Presently, the clinical significance 
of the observed stent fractures is uncertain. 
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868-5 Long-Term Outcome of Superficial Femoral Artery 
Stenting Using Self-Expandable Nitinol Stents 
Compared to Stainless Steel Stents: A Retrospective 
Multicenter Study 
Bibi Fatemeh Haverizadeh, Thomas Zeller, Hans Krankenberg, Dierk Scheinerl, Aljosha 
Rastan, Sven BrBunlich, Andrej Schmidt, Sylvia Geier. Susanne Ropers, Giancarlo 
Biamino, Herzzentrum Leipzig, Leipzig, Germany, Center for Cardiology, Angiology and 
Vascular Interventions, Hamburg, Germany 
Background: With the aim lo establish the long-term value of stenting long superiicial 
femoral artery (SFA) lesions, the data of four German high-volume centers were retro- 
spectively evaluated. 
Methods: Among consecutive SFA stenting procuedures in our centers during 1999- 
2000, 163 SFA stenting procedures using self-expanding nitinol stent (SMART stent, 
Cordis; Group S) were compared with 166 implantation procuedures using self-expand- 
able stainless steel stent (W&tent, Boston Scientific)in the same time window (Group 
W). Patients with in-stent stenting and multiple stent types in the same vessel were 
excluded. 
Results: Patients’ mean age was 66.5+/-10.1 and 32% were females wthout statistically 
significant difference between the two groups. Diabetics included 21% of the S group 
comparing 40% in the W group (p: 0.001). Clinical symptoms based on Rutherford crite- 
na were: (II: S: 19% vs W: lo%, Ill: S:72% vs W:77%, IV: S:5% vs W:lO%, V: S:3% vs 
W:3%; p: NS ). 16% of the Smart group had previous target lesion angioplasty comparing 
23% in the wallstent group (p: NS). There was no difference between the two groups 
comparing lesion length (S: 176+/-110 vs W: 197+/-101 mm p:NS), percent stenosis (S: 
97.9+/-4.6 vs W: 97.2+/-9.9 %) and number of stents (S&W: 1.6+/-l .O). Overall stented 
length was longer in the wallstent group (S: 120+/-76 vs W: 143+/-96 mm, p:O.O4). 
Mean follow-up pertod was 16.9+/-a months. Using Kaplan-Meier analaysis, one-year 
primary patency in the smart group was significantly higher compared to the wallstent 
group (S: 61+/-5% vs W: 30+/-5, p: 0.0000). One-year assisted primary patency 
increased lo 75+1-4% in the S group and 53+/-5% in the W group (p: 0.0000). Secondary 
patency at one-year was 79+/-4% in the S group vs. 64+/-5% in the W group (p: 0.007). 
Conclusion: - Stenting long SFA lesions with nitinol stents is associated wth a signifi- 
cantly better outcome comparing self-expandable stainless steel stents. 
- The long-term secondary patency of about 60% using nitinol stems demonstrates that 
this technology is safe, clinically very effectlve and comparable with reported surgical 
results. 
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868-6 Renal Angioplasty and Stenting Under Distal Protection 
Michel Hew, lsabelle Henry, Christos Klonarls. Mich&le Hugel, I.L.R.M.D.T., Nancy, 
France 
Purpose: Renal arlery stenting is safe & efficient but at least 20% of the patients have a 
deterioration of the renal function after the procedure. We evaluate feasibility and safety 
of renal artery angioplasty and stenting using a distal protection device to reduce the risk 
of intraprocedural artery embolism and to avoid deterioration of the renal function. Yeth- 
ods: 46 Hypertensive patients (26 men ; mean age 67.7 + 6.3 years, range (22-67) with 
atherosclerotic renal artery stenosis (6 bilateral) underwent angioplasty & stenting with 
distal protection in 52 renal arteries (46 ostial lesions). 3 patients had solitary kidney, 15 
renal insufficiency. The lesion was crossed either with a Guard Wire temporary occlusion 
balloon (n=36). which was inflated lo provide parenchyma protection or with a filter (EPI 
Filter) fn=l31. Analoauard fn=l) which allow a continuous flow. Generated debris was _ _ 
aspirated and analyzed, blood pressure and serum creatinine levels followed. 
Results: Immediate technical success = 100 %. All lesions exceot 1 were stented. Visi- 
ble debris was aspirated with the Percusurge or removed with filters. Mean particle num- 
ber and diameter = 96.1 * 60.0 per procedure (range 13.206) and 201.2 * 76.0 %m 
(range 36.6206), respectively. Mean renal artery occlusion time = 6.55 * 2.46 mn (range 
2.29-13.21) with the Percusurge Device. Mean time in situ (filters): 4.2 * 1.1 mn. 
Mean follow-up = 23.6 * 14 months (range 1:42). Systolic and diastolic blood pressure 
declined from 169.0 -t 15.1 & 104.0 t 13.0 mm Hg, respectively, lo 149.6 f 12.3 & 92.6 f 
6.7 mm Hg after procedure. The mean cretonne level remains constant during the follow- 
up. At 6 month follow up (31 patients); renal function did not deteriorate in any patient, 
whereas 6 patients with baseline renal insufficiency improved after the procedure. At 3 
years (19 patients) renal function deteriorated only I” 1 patient with renal insufficiency. 
The renal function remains improved in 5 patients. 
Conclusion: These first results suggest the feasibility and safety of distal protection dur- 
ing renal interventions to protect against atheroembolism and to avoid renal function 
deterioration. The beneficial effects should be evaluated by randomized studies. 
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877-1 An Optimal Diagnostic Threshold of Minimum Stent 
Area to Predict Long-Term Stent Patency Following 
Sirolimus-Eluting Stent Implantation: Serial 
Intravascular Ultrasound Analysis From the SIRIUS 
Trial 
Shinio Sonoda, Yoshihiro Merino, Junya Ako, Ali Hassan, Mark Reisman, Shing C. 
Wong, Theodore A. Bass, Alan C. Yeung, Martin B. Leon, Jeffrey W. Moses, Paul G. 
Yock. Yasuhiro Honda, Peter J. Fitzgerald, the SIRIUS Investigators. Stanford Universtty 
Medical Center, Stanford, CA, Lenox Hill Hospital, New York, NY 
Mintmum stent area (MSA) is a consistent predictor of instent restenosis. In bare metal 
stents (BMS). however, its predictive value is still limited because of biologic variability in 
the restenosis process. The aim of this study was to examine the diagnostic value of 
MSA in prediction of long-term patency of drug-eluting stent (sirolimus-eluting stents, 
SES) implantation compared to BMS. 
Methods: From the SIRIUS trial, 126 (SES 74; BMS 52) cases with complete serial IV&IS 
(baseline and 6 months follow-up) were analysed. MSA at post-procedure and minimum 
lumen area (MLA) at follow-up were obtained. Based on previous physiology studies. 
adequate stent patency at follow-up was defined as MLA > 4.0 mm2. 
Results: In both groups, a significant positive correlation was observed between base- 
line MSA and follow-up MLA (SES: p~O.0001, BMS: pcO.0001). However, SES showed 
higher correlation than BMS (0.60 vs. 0.65) with a higher regression coefficient (0.92 vs. 
0.59). The sensitivity and specificity curves identified different optimal diagnostic thresh- 
olds of MSA for adequate follow-up MLA: 5.0 mn? for SES and 6.5 mm2 for BMS. The 
positive predictive values with these cut-off points were 90% and 56%, respectively. 
Conclusions: Based on the SIRIUS IVUS substudy, in SES, MSA is a stronger predictor 
of outcome than in BMS, due to the reduction of biologic variability. In addition. SES has 
a considerably lower optimal MSA threshold (5.0 mm2) compared to BMS (6.5 mm2). 
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877-2 Influence of Calcium on Neointimal Growth Following 
Drug-Eluting and Bare Metal Stents Implantation: A 3-D 
Intravascular Ultrasound Substudy of the SCORE Trial 
Tow Kataoka. Yoshihiro Merino, Brian K. Courtney, Rachna Basisht, Seung-Ho Hur, 
Paul G. Yock, Eberhard Grube, Peter J. Fitzgerald, Yasuhiro Honda, for the SCORE 
Investigators, Stanford University, Stanford, CA, Heart Center Siegburg, Siegburg, 
Germany 
Background: Plaque characteristics may affect pharmacokinetics of drug-eluting stents 
and. therefore. neointimal (NI) orowth suooression. The aim of this studv was to examine 
I _  
the potential influence of plaque calcium (CA) deposits on NI growth following 7.hex- 
anovltaxol-elutino stent (DES) and bare metal stent fBMSI imolantation. 
” ~ , 
Methods: In SCORE, complete 6.month follow-up 3D IVUS data were available in 41 
lesions (DES: 22, BMS: 19). Volume indices (volume/stent length) were computed for 
stem (SVI), lumen (LVI), and neointima (NVI). Lumen and stent contours were extracted 
from the dataset at 0.5 mm intervals over the stented segment. The contours were then 
exporied into custom-designed software lo compute mean NI thickness within 12 
equally-spaced radial sectors in each frame, referenced from the stem center (DES: 
6.040. BMS: 7.224 sectors). The oresence and location of CA deooslt (none: N. suoerfi- 
cial: S, deep: D) were also evaluated at each sector. 
Results: Overall. DES reduced NI orowth cornoared to BMS 10.3iO.3 mmslmm vs 
2.7el.6 mmslmm, pcO.0001). In BMS, larger NI growth was observed at non-calctfied 
plaque segments compared to those with superficial or deep CA. In contrast, with DES 
the NI growth suppression was comparable I” calcified and non-calcified segments (Fig- 
WC?). 
JACC March 19,2003 ABSTRACTS - Angiography & Interventional Cardiology 81A 
Conclusions: These results suggest that plaque CA may influence NI growth with EMS. 
However, NI growth suppression of DES does not appear to be affected by the presence 
or location of CA. 
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877-5 Overlapping Sirolimus-Eluting Stents: Intravascular 
Ultrasound Analysis From the SIRIUS Trial 
11 :oo a.m. Methods: Serial IVUS date (post stent and E-month follow-w) were obtalned from SIR- 
877-3 Impact of Direct Stenting Guided by Intravascular 
Ultrasound on Clinical Outcome of Patients Treated for 
Native Coronary Disease 
Edouard F. Cheneau, Laurent Leborgne, Daniel A. Canes, August0 D. Plchard, Lowell F. 
Satler, William 0. Suddath, Neil J. Weissman, Ron Waksman, Washington Hospital 
Center, Washington, DC 
Background: Direct stenting (DS) was shown to reduce the vessel ~njuly and restenosis 
rate in animal models. DS did not translate into the reduction of events and restenosis in 
clinical practice when compared to conventional strategy with balloon predilatation (PD). 
The purpose of this study was to examine whether DS guided by intravascular ultrasound 
(IVUS) reduced further the restenosis and the events rate. 
IUS, a prospective, randomized, multicenter trial comparing SES vs. bare metal stent 
(BMS). Stent overlao was identified bv the visible double stent struts on IVUS cross sec- 
tlonal image. External elastic membrane (EEM) area. lumen area (LA), and stent area 
(SA) were obtained by analyzing the center of the overlapped stent segment. Neointimal 
area (NIA) was calculated es SA minus LA. 
Results: Out of 130 serial IVUS cases (BMS 54: SES 76), there were 30 stent overlap 
segments (overlap BMS 17: overlap SES 13) in 27 cases eligible for quantitative and 
qualitative analysis. There was one case of late incomplete apposition in overlap SES, 
which does not represent a statistically higher incidence compared to overlap BMS. As 
expected, neointimal proliferation was less in overlap SES than overlap BMS, but there 
were no significant effect on EEM. 
Conclusions: Excellent suppression of neointimal formation in SES was also observed 
in overlapped stent segment without compromising vessel dimension. 
Methods: We analyzed the in-hospital and l-year outcomes of patients who were 
treated with percutaneous coronary interventions and stem implantation when percuta- 
neous intervention was guided by IVUS. Only patients treated for single de nova lesions 
were included. 
overlap BMS overlap SES p-value 
(fl=l7) (n=13) 
Results: In 1386 patients, 251 (18.1%) were treated with direct stenting and 1135 
(71.9%) were treated with balloon predilatation. Pre- and post-procedure characteristics 
by angiography were similar in both groups. The reference lumen area by IVUS was 0.7 
* 3.1 mm’ in the DS group and 8.3 + 3.0 m&in the PD group (p=O.21). Post procedure 
minimal stent areas (7.55 + 2.53 mm2 in the DS group and 7.72 * 2.72 mm2 in the PD 
group, p=O.55) were similar in the two groups. Post-procedure non-Q-wave myocardial 
infarction occurred in 4.9% of the DS group and in 12.5% of the PD group (p=O.O05). At 
one-year follow-up, target leston revascularization rate was 4.9% in the DS group and 
14.8% in the PD group (p=O.OOS). Major cardiac event rate was 11.4% and 18.9% in the 
DS and PD groups, respectively (p=O.O16). Direct stenting strategy (OR=0.46, CI=O.25- 
0.65, p=O.O13) was independently correlated to lower risk for revascularization in multi- 
vanate analysis.Conclusion: Direct stenting assisted by intravascular ultrasound 
reduces post-procedural adverse events and the need for repeat revascularization at one 
year. 
EEM eree, ““2 POST 12.9k3.7 
FU 14.1*3.7 
LA, mm2 POST 6.2~2.0 
FU 4.5-tl.4 
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877-6 Exaggeration of Neointimal Formation Associated With 
the Critical Segment in Bare Metal Stenting 
11:15 a.m. Mamoo Nakamura, Toru Kataoka, Tadanori Aizawa. Hideo Tamai. Katsuhiro Kitamura, 
Lutz Bullesfeld, Yasuhiro Honda, Paul G. Yock, Peter J. Fitzgerald, Stanford University, 
Palo Alto, CA, Shiga Medical Center for Adults, Moriyama, Japan 877-4 Qualitative Assessment of Coronary Lesions Treated 
With Sirolimus-Eluting Stents: Serial Intravascular 
Ultrasound Analysis From the SIRIUS Trial 
Shinio Sonoda Toru Kataoka, Yoshihiro Morino, Junya Ako, Ali Hassan, Emerson C. 
Perin, Robert L. Wilensky, Lowell Satler, Yasuhiro Honda, Paul G. Yock, Marlin B. Leon, 
Jeffrey W. Moses, Peter J. Fitzgerald. the SIRIUS investigators, Stanford University 
Medical Center, Stanford. CA, Lenox Hill Hospital, New York, NY 
The aim of this study was to examine detailed morphologic characteristw of local bio- 
logic response after drug-eluting stent (sirolimus-eluting stents, SES) implantation com- 
pared with bare metal stents (BMS). 
Methods: In the SIRIUS trial, serial IVUS (baseline and E-months) studies in 130 (SES 
76; BMS 54) lesions were carefully reviewed for evidence of instent thrombus. persistent 
edge tears, or stent incomplete apposition (IA) by 3 independent I blinded analysts. IA 
was further classified Into 3 types: A) absolute (>l struts separated from the vessel wall 
with evidence of blood speckle behind the struts), B) branch associated, and C) inter- 
strut cavities (struts not clearly separated from the vessel but cavities observed between 
the struts). 
Results: Serial IVUS revealed no evidence of instent thrombue or persistent edge tears 
in either group. Among 21 Type-A IA segments observed at follow-up (SES 15 (20%): 
BMS 6 (1 l%), p=ns). 6 BMS and 6 SES segments had IA at baseline (persistent IA). 
Type-B was frequently observed in both groups. However, all jailed branches remained 
patent at follow-up. There was a higher incidence of Type-C in SES than BMS (12% YS 
2%, pco.05). 
Conclusions: In this trial, Implantation of SES was not associated with late instent 
thrombus, persistent edge tears, or late branch occlusion. Morphologic characteristics of 
IA appeared to be different between drug-eluting stems and conventional BMS. Further 
studies will be needed to clarify the significance of these observatlons. 
Yoshihiro Morinq Junya Ako, Yasuhlro Honda. Shinjo Sonoda, Mitsuyasu Terashima, Ali 
Hassan, David R. Holmes, David 0. Williams, Tim A. Fischell. Emily Keim, Paul G. Yock, 
Martin 8. Leon, Jeffrey W. Moses, Peter J. Fitzgerald, the SIRIUS investigators, Stanford 
University, Stanford, CA, ltabashi Chuo MedIcal Center, Tokyo, Japan 
Background: Excellent suppression of neointimal hyperplasia after sirolimus-eluting 
stent (SES) implantation has been previously reported. The late effect of SES stent over- 
lapping on neointimal formation and vessel dimensions, however, has not been westi- 
gated. 
Background: To evaluate the focal impact of the pre-intervention “critical segment” on 
neointimal hyperplasia after stent implantation. 
Methods & Results: Serial (pre, post-stem and B-months follow-up) volumetric IVUS 
analysis was performed in 66 lesions treated with single stent implantation (ACS Multi- 
link, 15”” in length). Within the stented segment, a pre-intervention ‘“critical segment” 
was identified as the segment with lumen area (LA) less than 4 mr$. The remaining seg- 
ment(s) were defined es ‘“non-critical”. Average stent @A), LA, plaque (PA) and intimal 
areas (IA) were calculated to normalize with respect to different segment lengths, and 
percent IA was calculated to standardize SA. At pre-intervention. mean critical segment 
length was 7.06i2.76 mm. Immediately post stewing, baseline SA was smaller 
(8.26*1.96 vs.. 6.62 tl.66 “d/mm, p=O.OOl) and PA was greater (8.65+2.40 vs. 
6.04e2.26 mr!i?mm, p=O.O03) in the critical segment compared to the non-critical seg- 
ment(s). At 6-months, both IA (2.92+1.36 vs. 2.62el.25 mm3/mm, p=O.O13) and percent 
IA (36 vs. 31%, p=O.o002) were greater in critical than in non-critical segment(s). 
Because of potential impact of residual plaque burden or vessel stretch during the base- 
line procedure on intimal hyperplasia. correlation of IA and post-stem PA or periproce- 
dural VA change were examined. However, no correlation between IA and residual PA or 
VA change was observed either !n critical or non-critical segment(s) or combination of 
both. 
Conclusions: Within the stent, greater intimal hyperplasia developed I” the critical seg- 
ment compared to non-critical segment(s), without correlation with residual plaque bur- 
den or vessel stretch. These observations that the biology of restenosis is different in the 
critical segment may have an implication for the dosing/distribution of antirestenotic ther- 
apies. 
